Cargando…
ADRB2 inhibition combined with antioxidant treatment alleviates lung fibrosis by attenuating TGFβ/SMAD signaling in lung fibroblasts
Idiopathic pulmonary fibrosis is a progressive and fatal interstitial lung disease with a poor prognosis and limited therapeutic options, which is characterized by aberrant myofibroblast activation and pathological remodeling of the extracellular matrix, while the mechanism remains elusive. In the p...
Autores principales: | Wan, Ruyan, Wang, Lan, Duan, Yudi, Zhu, Miaomiao, Li, Wenwen, Zhao, Mengxia, Yuan, Hongmei, Xu, Kai, Li, Zhongzheng, Zhang, Xiao, Yu, Guoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624856/ https://www.ncbi.nlm.nih.gov/pubmed/37923730 http://dx.doi.org/10.1038/s41420-023-01702-9 |
Ejemplares similares
-
Cellular Senescence: A Troy Horse in Pulmonary Fibrosis
por: Wan, Ruyan, et al.
Publicado: (2023) -
Artificial neural network identified the significant genes to distinguish Idiopathic pulmonary fibrosis
por: Li, Zhongzheng, et al.
Publicado: (2023) -
ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation
por: Chen, Dongxin, et al.
Publicado: (2022) -
Ginsenoside Rg2 alleviates myocardial fibrosis by regulating TGF-β1/Smad signalling pathway
por: Wang, Quanwei, et al.
Publicado: (2021) -
Pirfenidone Alleviates Choroidal Neovascular Fibrosis through TGF-β/Smad Signaling Pathway
por: Gao, Chuang, et al.
Publicado: (2021)